ArticleScientific reports2017

Efficacy of alirocumab according to background statin type and dose: pooled analysis of 8 ODYSSEY Phase 3 clinical trials.

Alberico L Catapano et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.